4th Quarter - Report

TCH GROUP, LLC for AMGEN USA INC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Biosimilars S. 1695, Biologics Price Competition and Innovation Act of 2007 HR 3590, Patient Protection and Affordable Care Act

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE

Bills named: H.R. 3590 (111th), S. 1695 (111th)

Medicare/Medicaid MMM

Medicare Coverage Reimbursement Issues Implementation of the Medicaid Drug Rebate Program

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.